Hemophagocytic lymphohistiocytosis in adults: Diagnosis and treatment

被引:73
作者
Larroche, Claire [1 ]
机构
[1] Univ Paris 13, CHU Avicenne, Serv Med Interne, F-93009 Bobigny, France
关键词
Macrophage activation syndrome; Hemophagocytic lymphohistiocytosis; MACROPHAGE ACTIVATION SYNDROME; LOW GLYCOSYLATED FERRITIN; CYCLOSPORINE-A; MUTATIONS; DISEASE; HYPERFERRITINEMIA; HISTIOCYTOSIS; GUIDELINES; PATIENT; MARKER;
D O I
10.1016/j.jbspin.2011.10.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hemophagocytic lymphohistiocytosis occurring as a primary or acquired disorder is a condition of chaotic and uncontrolled immune system stimulation. Cytotoxic cells and macrophages cause multiorgan damage, hemophagocytosis, and severe systemic inflammation. Clinical manifestations include a fever, organ enlargement, and weight loss. Laboratory tests show bicytopenia or pancytopenia, cytolysis and cholestasis, serum ferritin elevation, and clotting disorders. The reference standard for the diagnosis remains the presence in histological specimens of hemophagocytic macrophages, which may be lacking early in the disease, leading to diagnostic challenges. Inherited forms produce symptoms in early childhood and are fatal in the absence of specific treatment. In adults, the clinical spectrum ranges from mild and self-limited hemophagocytic lymphohistiocytosis to rapidly fatal multiorgan failure. Many questions remain unresolved regarding the diagnosis and treatment in adults. This update is an attempt at providing answers. (C) 2011 Societe francaise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:356 / 361
页数:6
相关论文
共 55 条
[1]   Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis [J].
Allen, Carl E. ;
Yu, Xiaoying ;
Kozinetz, Claudia A. ;
McClain, Kenneth L. .
PEDIATRIC BLOOD & CANCER, 2008, 50 (06) :1227-1235
[2]  
AMBRUSO DR, 1980, CANCER, V45, P2516, DOI 10.1002/1097-0142(19800515)45:10<2516::AID-CNCR2820451008>3.0.CO
[3]  
2-V
[4]  
[Anonymous], 1983, LANCET, V1, P455
[5]  
Athreya BH, 2002, CLIN EXP RHEUMATOL, V20, P121
[6]   Critical care management of patients with hemophagocytic lymphohistiocytosis [J].
Buyse, Sophie ;
Teixeira, Luis ;
Galicier, Lionel ;
Mariotte, Eric ;
Lemiale, Virginie ;
Seguin, Amelie ;
Bertheau, Philippe ;
Canet, Emmanuel ;
de Labarthe, Adrienne ;
Darmon, Michael ;
Rybojad, Michel ;
Schlemmer, Benoit ;
Azoulay, Elie .
INTENSIVE CARE MEDICINE, 2010, 36 (10) :1695-1702
[7]   Short-term tolerance of three days pulse methyprednisolone therapy:: a prospective study in 146 patients [J].
Chibane, S ;
Feldman-Billard, S ;
Rossignol, I ;
Kassaei, R ;
Mihoubi-Mantout, F ;
Héron, E .
REVUE DE MEDECINE INTERNE, 2005, 26 (01) :20-26
[8]   Molecular mechanisms of biogenesis and exocytosis of cytotoxic granules [J].
de Saint Basile, Genevieve ;
Menasche, Gael ;
Fischer, Alain .
NATURE REVIEWS IMMUNOLOGY, 2010, 10 (08) :568-579
[9]   Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes [J].
Emmenegger, U ;
Frey, U ;
Reimers, A ;
Fux, C ;
Semela, D ;
Cottagnoud, P ;
Spaeth, PJ ;
Neftel, KA .
AMERICAN JOURNAL OF HEMATOLOGY, 2001, 68 (01) :4-10
[10]  
ESUMI N, 1987, NEW ENGL J MED, V316, P346